Discontinuation report BRETYLIUM TOSYLATE INJECTION USP
| Report ID | 31958 |
| Drug Identification Number | 02185377 |
| Brand name | BRETYLIUM TOSYLATE INJECTION USP |
| Common or Proper name | bretylium |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | BRETYLIUM TOSYLATE |
| Strength(s) | 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 5 x 10ML VIALS |
| ATC code | C01BD |
| ATC description | ANTIARRHYTHMICS, CLASS I AND III |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2017-12-04 |
| Remaining supply date | 2017-12-15 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2017-12-06 | French | Compare |
| v1 | 2017-12-06 | English | Compare |
Showing 1 to 2 of 2